Product Details:
Alternate Name | 5-((7-Cl-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione); 7-Cl-O-Nec-1 |
---|
Peptide Sequence | No |
---|
Appearance | Yellow solid |
---|
CAS # | 852391-15-2 |
---|
Molecular Formula | C₁₃H₁₂ClN₃O₂ |
---|
Molecular Weight | 277.71 |
---|
Purity | ≥96% by TLC and LC-MS |
---|
Solubility | DMSO |
---|
SMILES | CN1C(=O)C(NC1=O)CC2=CNC3=C2C=CC=C3Cl |
---|
InChi | InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19) |
---|
InChi Key | WIKGAEMMNQTUGL-UHFFFAOYSA-N |
---|
PubChem CID | 643953 |
---|
Handling | Protect from light and moisture |
---|
Storage Conditions | -20°C |
---|
Shipping Conditions | Gel Pack |
---|
USAGE | For Research Use Only! Not For Use in Humans. |
---|
biovision nec 1s
Descriptions:
A potent necroptosis inhibitor. Displays higher activity in inhibiting necroptosis in Jurkat cells than Nec-1 (Cat. No. 1864) (EC₅₀ = 210 nM versus EC₅₀ = 490 nM), as well as showing no nonspecific cytotoxicity at high concentrations (~100 mM). More useful for in-cell and in vivo experiments compared to Nec-1.
Abstract
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment that would effectively slow the growth of the aneurysm or prevent rupture. Necrosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs). We have recently shown that a lack of RIP3 in mice prevented aneurysm formation.
The mean aortic diameter of Nec-1-treated mice appeared to be smaller (121.60 ± 10.40%) than the DMSO group, although the difference was not statistically significant (P = 0.1). Histologically, the aortic structure of Nec-1s-treated mice appeared normal, with continuous and organized elastin layers and rich SMCs expressing αActin.
In addition, Nect-1 treatment reduced macrophage infiltration and MMP9 accumulation and increased tropoelastin and lysyl oxidase aortic levels. Together, our data suggest that pharmacological inhibition of necrosis by Nec-1 stabilizes pre-existing aneurysms by reducing inflammation and promoting connective tissue repair.
NOMO-1s |
ABL-TC0480 | AcceGen | 1 vial | Ask for price |
Description: NOMO-1s Cell Line is from human; Tissue: hemo-lymphocytic; Morphology: round; Profile: This cell line is useful for studying the differentiation and maturation of monocytes. |
(1S)-Calcitriol |
T35524-10mg | TargetMol Chemicals | 10mg | Ask for price |
- SMILES: [H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
- Formula: C27H44O3
|
Description: (1S)-Calcitriol |
(1S)-Calcitriol |
T35524-1g | TargetMol Chemicals | 1g | Ask for price |
- SMILES: [H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
- Formula: C27H44O3
|
Description: (1S)-Calcitriol |
(1S)-Calcitriol |
T35524-1mg | TargetMol Chemicals | 1mg | Ask for price |
- SMILES: [H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
- Formula: C27H44O3
|
Description: (1S)-Calcitriol |
(1S)-Calcitriol |
T35524-50mg | TargetMol Chemicals | 50mg | Ask for price |
- SMILES: [H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
- Formula: C27H44O3
|
Description: (1S)-Calcitriol |
(1S)-Calcitriol |
T35524-5mg | TargetMol Chemicals | 5mg | Ask for price |
- SMILES: [H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O
- Formula: C27H44O3
|
Description: (1S)-Calcitriol |
IQ-1S |
abx282388-100g | Abbexa | 100 µg | Ask for price |
IQ-1S |
abx282388-20g | Abbexa | 20 µg | EUR 118.75 |
IQ-1S |
abx282388-50g | Abbexa | 50 µg | EUR 225 |
(1S)-Chrysanthemolactone |
TN2671-10mg | TargetMol Chemicals | 10mg | Ask for price |
- SMILES: CC1(C)[C@]2([C@@]1(C(=O)OC(C)(C)C2)[H])[H]
- Formula: C10H16O2
|
Description: (1S)-Chrysanthemolactone |
(1S)-Chrysanthemolactone |
TN2671-1g | TargetMol Chemicals | 1g | Ask for price |
- SMILES: CC1(C)[C@]2([C@@]1(C(=O)OC(C)(C)C2)[H])[H]
- Formula: C10H16O2
|
Description: (1S)-Chrysanthemolactone |
(1S)-Chrysanthemolactone |
TN2671-1mg | TargetMol Chemicals | 1mg | Ask for price |
- SMILES: CC1(C)[C@]2([C@@]1(C(=O)OC(C)(C)C2)[H])[H]
- Formula: C10H16O2
|
Description: (1S)-Chrysanthemolactone |
(1S)-Chrysanthemolactone |
TN2671-50mg | TargetMol Chemicals | 50mg | Ask for price |
- SMILES: CC1(C)[C@]2([C@@]1(C(=O)OC(C)(C)C2)[H])[H]
- Formula: C10H16O2
|
Description: (1S)-Chrysanthemolactone |
(1S)-Chrysanthemolactone |
TN2671-5mg | TargetMol Chemicals | 5mg | Ask for price |
- SMILES: CC1(C)[C@]2([C@@]1(C(=O)OC(C)(C)C2)[H])[H]
- Formula: C10H16O2
|
Description: (1S)-Chrysanthemolactone |
MM.1S |
CSC-C9219W | Creative Bioarray | One Frozen vial | Ask for price |
Description: Leukemia - Lymphoma - Myeloma Cells |
(1S)-Calcitriol |
MBS5796866-1mg | MyBiosource | 1(mg | EUR 1480 |
(1S)-Calcitriol |
MBS5796866-5x1mg | MyBiosource | 5x1(mg | EUR 6510 |
(1S)-Camphorsultam |
MBS6114899-1g | MyBiosource | 1(g | EUR 485 |
(1S)-Camphorsultam |
MBS6114899-5x1g | MyBiosource | 5x1g | EUR 2025 |